News coverage about Cabot (NYSE:CBT) has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cabot earned a coverage optimism score of 0.15 on Accern’s scale. Accern also assigned news headlines about the specialty chemicals company an impact score of 46.3955755705686 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Here are some of the news headlines that may have impacted Accern Sentiment’s rankings:

Several analysts have weighed in on CBT shares. Loop Capital raised shares of Cabot from a “hold” rating to a “buy” rating and set a $82.00 price target for the company in a research note on Friday, January 5th. Zacks Investment Research downgraded shares of Cabot from a “buy” rating to a “hold” rating in a research note on Tuesday, November 7th. Jefferies Group reissued a “buy” rating and issued a $74.00 price target on shares of Cabot in a research note on Friday, November 3rd. KeyCorp reissued a “hold” rating on shares of Cabot in a research note on Wednesday, November 1st. Finally, SunTrust Banks raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Tuesday, December 19th. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $64.43.

Cabot (NYSE CBT) traded up $0.84 during mid-day trading on Friday, hitting $67.24. 314,287 shares of the company’s stock were exchanged, compared to its average volume of 449,316. Cabot has a 12-month low of $50.21 and a 12-month high of $67.45. The stock has a market capitalization of $4,113.46, a PE ratio of 17.65, a price-to-earnings-growth ratio of 1.75 and a beta of 1.11. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.70 and a quick ratio of 1.17.

Cabot (NYSE:CBT) last released its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.93 by ($0.02). Cabot had a net margin of 8.87% and a return on equity of 15.11%. The firm had revenue of $723.00 million during the quarter, compared to analysts’ expectations of $683.30 million. During the same quarter in the previous year, the firm posted $1.00 EPS. Cabot’s revenue was up 16.8% compared to the same quarter last year. research analysts expect that Cabot will post 3.79 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 9th. Shareholders of record on Friday, February 23rd will be given a $0.315 dividend. This represents a $1.26 dividend on an annualized basis and a dividend yield of 1.87%. Cabot’s payout ratio is 33.07%.

COPYRIGHT VIOLATION NOTICE: This news story was posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Insider Buying and Selling by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with's FREE daily email newsletter.